Two Variants of a Gut Protein Seen to Have Opposite Roles in Colitis and Colon Cancer Risk

Two Variants of a Gut Protein Seen to Have Opposite Roles in Colitis and Colon Cancer Risk
A team of researchers at the University of California, Riverside, found that a tight control of the levels of two forms of the same protein, hepatocyte nuclear factor 4-alpha (HNF4-α), is critical to prevent intestinal diseases. The findings are described in the study, “Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer,” published in the

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *